Recruiting

Tocilizumab in Lung Transplantation

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(21 sites)

United States

St. Joseph's Hospital and Medical Center (Site #: 71192), Phoenix, Arizona

Cedars Sinai Medical Center (Site #: 71146), Beverly Hills, California

David Geffen School of Medicine at UCLA (Site #: 71123), Los Angeles, California

University of Florida Shands Hospital (Site #: 71131), Gainesville, Florida

Emory University (Site #: 71103), Atlanta, Georgia

University of Maryland Medical Center (Site #: 71138), Baltimore, Maryland

Massachusetts General Hospital (Site #: 71107), Boston, Massachusetts

Boston Children's Hospital and Harvard Medical School (Site #: 71001), Boston, Massachusetts

Mayo Clinic Rochester (Site #: 71160), Rochester, Minnesota

Barnes Jewish Hospital/ Washington University SOM (Site #: 71191), St Louis, Missouri

St. Louis Children's Hospital of Washington University (Site #: 71006), St Louis, Missouri

Columbia University Medical Center (Site #: 71113), New York, New York

Duke University Medical Center (Site #: 71139), Durham, North Carolina

Cleveland Clinic (Site #: 71101), Cleveland, Ohio

Ohio State University Medical Center (Site #: 71196), Columbus, Ohio

Temple University (Site #: 71197), Philadelphia, Pennsylvania

Vanderbilt University (Site #: 71174), Nashville, Tennessee

University of Texas Southwestern (Site #: 71187), Dallas, Texas

Houston Methodist Hospital (Site #: 71120), Houston, Texas

University of Texas Health Science at San Antonio (Site #: 71198), San Antonio, Texas

University of Utah Medical Center (Site #: 71126), Salt Lake City, Utah